ARK Genomic Revolution ETF
ARKG
5 hedge funds and large institutions have $648K invested in ARK Genomic Revolution ETF in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
5.11% less ownership
Funds ownership: 13.16% → 8.05% (-5.1%)
28% less capital invested
Capital invested by funds: $897K → $648K (-$249K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$44.3K |
| 2 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
+$2.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$434K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $454K | -$434K | -23,210 | -50% |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $68K | – | – | – |
|
|
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
| $58K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $47K | +$44.3K | +2,368 | New |
|
|
HFM
5
Hartford Financial Management
Hartford,
Connecticut
| $21K | +$2.94K | +157 | +17% |
|
ARKG Hedge Fund Activity: Q3 2016 in Review
5 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2016, worth a combined $648K — down 28% from $897K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARKG positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $44.3K. The largest seller was Jane Street, cutting an estimated $434K.
- 5 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2016, up from 4 in Q2 2016.
- Funds reported $648K of ARK Genomic Revolution ETF stock for Q3 2016, down 28% quarter-over-quarter.
- 1 fund opened new ARK Genomic Revolution ETF positions in Q3 2016 and 0 closed out, a net change of +1 holder.
- The largest ARK Genomic Revolution ETF buyer in Q3 2016 was UBS Group, an estimated $44.3K added.
- The largest ARK Genomic Revolution ETF seller in Q3 2016 was Jane Street, an estimated $434K sold.
Based on aggregated 13F filings for Q3 2016.